Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia

por Galluppi, Gerald R., Polhamus, Daniel G., Fisher, Jeannine M., Hopkins, Seth C., Koblan, Kenneth S.
Publicado 2021

A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment o...

por Gross, Jorge Luiz, Rogers, James, Polhamus, Daniel, Gillespie, William, Friedrich, Christian, Gong, Yan, Monz, Brigitta Ursula, Patel, Sanjay, Staab, Alexander, Retlich, Silke
Publicado 2013

A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects

por Tsukada, Hironobu, Chen, Yu-Luan, Xiao, Guangqing, Lennek, Lisa, Milanovic, Snezana M., Worden, MaryAlice, Polhamus, Daniel G., Chiu, Yu-Yuan, Hopkins, Seth C., Galluppi, Gerald R.
Publicado 2023

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

por Yin, Ophelia, Zahir, Hamim, French, Jonathan, Polhamus, Daniel, Wang, Xiaoning, van de Sande, Michiel, Tap, William D., Gelderblom, Hans, Wagner, Andrew J., Healey, John H., Greenberg, Jonathan, Shuster, Dale, Stacchiotti, Silvia
Publicado 2021